Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros

Base de dados
País/Região como assunto
Ano de publicação
Tipo de documento
País de afiliação
Intervalo de ano de publicação
1.
Clin Endocrinol (Oxf) ; 79(1): 14-9, 2013 Jul.
Artigo em Inglês | MEDLINE | ID: mdl-22747889

RESUMO

OBJECTIVE: Despite the widespread use of the short synacthen test (SST), there remains no clear consensus on sampling times for the measurement of serum cortisol that best determines adrenal reserve. We set out to establish whether there is any value in measuring serum cortisol at 60 min following administration of synacthen. DESIGN: Retrospective data analysis of 500 SST results measuring 0, 30 and 60 min cortisol levels after administration of 250 µg of synacthen at 2 large urban National Health Teaching Hospitals in the UK. PATIENTS AND MEASUREMENTS: Individuals thought to have primary or secondary adrenal insufficiency given 250 µg of synacthen. MEASUREMENTS: Serum cortisol levels measured at 0, 30 and 60 min, looking to see how many people who had adrenal insufficiency at the 30 min sample but in whom the 60 min sample showed adequate adrenal reserve. RESULTS: The results from 384 people were analysed. A total of 276 had normal responses at 30 min and also at 60 min. A sum of 33 individuals had 'insufficient' (i.e., <550 nmol/l) 30 min cortisol levels, rising to ≥ 550 nmol/l at the 60 min test. All 75 individuals who were insufficient at 60 min were also insufficient at 30 min. No individuals passed (≥550 nmol/l) at 30 min and then failed (<550 nmol/l) at 60 min. CONCLUSIONS: These results suggest that a significant proportion of people undergoing a SST may be inappropriately diagnosed as having adrenal insufficiency if the 60 min sample is not measured. We suggest that the 60 min sample is measured in all individuals having a SST to prevent unnecessary over-diagnosis of adrenal insufficiency.


Assuntos
Insuficiência Adrenal/sangue , Insuficiência Adrenal/diagnóstico , Cosintropina , Hidrocortisona/sangue , Adulto , Idoso , Cosintropina/administração & dosagem , Feminino , Hormônios/administração & dosagem , Hospitais de Ensino , Humanos , Masculino , Pessoa de Meia-Idade , Curva ROC , Estudos Retrospectivos , Fatores de Tempo , Reino Unido
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA